Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoMed Pharmaceuticals Inc (NASDAQ:OMED)

9.31
Delayed Data
As of Feb 05
 -0.20 / -2.10%
Today’s Change
8.54
Today|||52-Week Range
29.83
-58.70%
Year-to-Date

Today’s Trading

Previous close9.51
Today’s open9.52
Day’s range9.21 - 9.52
Volume186,717
Average volume (3 months)256,584
Market cap$280.3M
Dividend yield--
Data as of 3:59pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+12.44%
Earnings growth (this year)+6.21%
Earnings growth (next 5 years)--
Revenue growth (last year)+4.71%
P/E ratioNM
Price/Sales16.32
Price/Book3.64

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...-0.26-4.35%
AKBAAkebia Therapeutics ...-0.27-3.50%
VTLVital Therapies Inc-0.05-0.54%
VSARVersartis Inc-0.32-3.31%
Data as of 4:14pm ET, 02/05/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)$0.41
Annual revenue (last year)$39.6M
Annual profit (last year)-$50.0M
Net profit margin-126.42%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Paul J. Hastings
CFO, SVP-Corporate Development &
Finance
Sunil Patel
Corporate headquarters
Redwood City, California

Forecasts

Partner Offers